Hill Dominic, Rose Barbara, Pajkos Aniko, Robinson Michael, Bye Peter, Bell Scott, Elkins Mark, Thompson Barbara, Macleod Colin, Aaron Shawn D, Harbour Colin
Department of Infectious Diseases and Immunology, University of Sydney, Sydney, Australia.
J Clin Microbiol. 2005 Oct;43(10):5085-90. doi: 10.1128/JCM.43.10.5085-5090.2005.
Recent studies have determined that Pseudomonas aeruginosa can live in a biofilm mode within hypoxic mucus in the airways of patients with cystic fibrosis (CF). P. aeruginosa grown under anaerobic and biofilm conditions may better approximate in vivo growth conditions in the CF airways, and combination antibiotic susceptibility testing of anaerobically and biofilm-grown isolates may be more relevant than traditional susceptibility testing under planktonic aerobic conditions. We tested 16 multidrug-resistant isolates of P. aeruginosa derived from CF patients using multiple combination bactericidal testing to compare the efficacies of double and triple antibiotic combinations against the isolates grown under traditional aerobic planktonic conditions, in planktonic anaerobic conditions, and in biofilm mode. Both anaerobically grown and biofilm-grown bacteria were significantly less susceptible (P < 0.01) to single and combination antibiotics than corresponding aerobic planktonically grown isolates. Furthermore, the antibiotic combinations that were bactericidal under anaerobic conditions were often different from those that were bactericidal against the same organisms grown as biofilms. The most effective combinations under all conditions were colistin (tested at concentrations suitable for nebulization) either alone or in combination with tobramycin (10 microg ml(-1)), followed by meropenem combined with tobramycin or ciprofloxacin. The findings of this study illustrate that antibiotic sensitivities are dependent on culture conditions and highlight the complexities of choosing appropriate combination therapy for multidrug-resistant P. aeruginosa in the CF lung.
近期研究已确定,铜绿假单胞菌可在囊性纤维化(CF)患者气道的低氧黏液中以生物膜模式生存。在厌氧和生物膜条件下生长的铜绿假单胞菌可能更接近CF气道中的体内生长条件,对厌氧和生物膜生长的分离株进行联合抗生素敏感性测试可能比传统的有氧浮游条件下的敏感性测试更具相关性。我们使用多种联合杀菌测试对16株源自CF患者的多重耐药铜绿假单胞菌分离株进行了测试,以比较双重和三重抗生素组合对在传统有氧浮游条件、浮游厌氧条件和生物膜模式下生长的分离株的疗效。与相应的有氧浮游生长的分离株相比,厌氧生长和生物膜生长的细菌对单一抗生素和联合抗生素的敏感性均显著降低(P<0.01)。此外,在厌氧条件下具有杀菌作用的抗生素组合往往与对以生物膜形式生长的相同菌株具有杀菌作用的组合不同。在所有条件下最有效的组合是单独使用黏菌素(以适合雾化的浓度进行测试)或与妥布霉素(10μg/ml)联合使用,其次是美罗培南与妥布霉素或环丙沙星联合使用。本研究结果表明,抗生素敏感性取决于培养条件,并突出了为CF肺部多重耐药铜绿假单胞菌选择合适联合治疗方案的复杂性。